Literature DB >> 11122751

Pathophysiology of atherosclerosis: development, regression, restenosis.

M R Adams1, S Kinlay, G J Blake, J L Orford, P Ganz, A P Selwyn.   

Abstract

There is now a very large number of patients with coronary artery disease who have also undergone percutaneous interventions such as coronary angioplasty. Atherosclerosis and restenosis are two distinct pathologic processes with different underlying pathophysiologic mechanisms, different natural histories, different clinical presentations, and treatment strategies. Management strategies to target both processes are currently poorly applied in clinical practice. The development of integrated management strategies to target atherosclerosis, as well as restenosis in the postprocedural period remains a priority.

Entities:  

Mesh:

Year:  2000        PMID: 11122751     DOI: 10.1007/s11883-000-0027-y

Source DB:  PubMed          Journal:  Curr Atheroscler Rep        ISSN: 1523-3804            Impact factor:   5.113


  53 in total

1.  Antioxidants and atherosclerosis. A current assessment.

Authors:  D Steinberg
Journal:  Circulation       Date:  1991-09       Impact factor: 29.690

Review 2.  Cell cycle progression: new therapeutic target for vascular proliferative disease.

Authors:  R C Braun-Dullaeus; M J Mann; V J Dzau
Journal:  Circulation       Date:  1998-07-07       Impact factor: 29.690

Review 3.  Endothelial, platelet and leukocyte interactions in ischemic heart disease: insights into potential mechanisms and their clinical relevance.

Authors:  J L Dinerman; J L Mehta
Journal:  J Am Coll Cardiol       Date:  1990-07       Impact factor: 24.094

4.  Vessel size, antioxidants, and restenosis: never too small, not too little, but often too late.

Authors:  E R Edelman
Journal:  Circulation       Date:  1998-02-10       Impact factor: 29.690

5.  Atherosclerosis impairs endothelium-dependent vascular relaxation to acetylcholine and thrombin in primates.

Authors:  P C Freiman; G G Mitchell; D D Heistad; M L Armstrong; D G Harrison
Journal:  Circ Res       Date:  1986-06       Impact factor: 17.367

6.  Cigarette smoking and platelet adhesion.

Authors:  R M Pittilo; J M Clarke; D Harris; I J Mackie; P M Rowles; S J Machin; N Woolf
Journal:  Br J Haematol       Date:  1984-12       Impact factor: 6.998

7.  Physician noncompliance with the 1993 National Cholesterol Education Program (NCEP-ATPII) guidelines.

Authors:  J P Frolkis; S J Zyzanski; J M Schwartz; P S Suhan
Journal:  Circulation       Date:  1998-09-01       Impact factor: 29.690

8.  In-stent restenosis: contributions of inflammatory responses and arterial injury to neointimal hyperplasia.

Authors:  R Kornowski; M K Hong; F O Tio; O Bramwell; H Wu; M B Leon
Journal:  J Am Coll Cardiol       Date:  1998-01       Impact factor: 24.094

9.  Thromboxane biosynthesis, neutrophil and coagulative activation in type IIa hypercholesterolemia.

Authors:  G Davì; A Ganci; M Averna; C Giammarresi; C Barbagallo; I Catalano; A Calà; A Notarbartolo
Journal:  Thromb Haemost       Date:  1995-10       Impact factor: 5.249

10.  The smooth muscle cell: sinner or saint in restenosis and the acute coronary syndromes?

Authors:  A Lafont; P Libby
Journal:  J Am Coll Cardiol       Date:  1998-07       Impact factor: 24.094

View more
  1 in total

1.  Surface modification and direct plasma amination of L605 CoCr alloys: on the optimization of the oxide layer for application in cardiovascular implants.

Authors:  Sergio Diaz-Rodriguez; Pascale Chevallier; Carlo Paternoster; Vanessa Montaño-Machado; Céline Noël; Laurent Houssiau; Diego Mantovani
Journal:  RSC Adv       Date:  2019-01-17       Impact factor: 3.361

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.